ATE338033T1 - Thiophen- und thiazolsulfonamide als antineoplastische mittel - Google Patents
Thiophen- und thiazolsulfonamide als antineoplastische mittelInfo
- Publication number
- ATE338033T1 ATE338033T1 AT02802117T AT02802117T ATE338033T1 AT E338033 T1 ATE338033 T1 AT E338033T1 AT 02802117 T AT02802117 T AT 02802117T AT 02802117 T AT02802117 T AT 02802117T AT E338033 T1 ATE338033 T1 AT E338033T1
- Authority
- AT
- Austria
- Prior art keywords
- thiazolesulfonamides
- thiophene
- antineoplastic agents
- antineoplastic
- agents
- Prior art date
Links
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 title 2
- 229940034982 antineoplastic agent Drugs 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 229930192474 thiophene Natural products 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35201201P | 2001-10-25 | 2001-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE338033T1 true ATE338033T1 (de) | 2006-09-15 |
Family
ID=23383421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02802117T ATE338033T1 (de) | 2001-10-25 | 2002-10-15 | Thiophen- und thiazolsulfonamide als antineoplastische mittel |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7084170B2 (https=) |
| EP (1) | EP1442030B1 (https=) |
| JP (1) | JP4464681B2 (https=) |
| KR (1) | KR100913471B1 (https=) |
| CN (1) | CN1298709C (https=) |
| AR (1) | AR037248A1 (https=) |
| AT (1) | ATE338033T1 (https=) |
| AU (1) | AU2002334817B2 (https=) |
| BR (1) | BR0212386A (https=) |
| CA (1) | CA2463300C (https=) |
| CY (1) | CY1106247T1 (https=) |
| DE (1) | DE60214413T2 (https=) |
| DK (1) | DK1442030T3 (https=) |
| EA (1) | EA006081B1 (https=) |
| EC (1) | ECSP045078A (https=) |
| EG (1) | EG26021A (https=) |
| ES (1) | ES2269816T3 (https=) |
| HR (1) | HRP20040371B1 (https=) |
| HU (1) | HUP0401638A3 (https=) |
| IL (2) | IL160851A0 (https=) |
| MX (1) | MXPA04003886A (https=) |
| MY (1) | MY130718A (https=) |
| NO (1) | NO20041316L (https=) |
| NZ (1) | NZ531136A (https=) |
| PE (1) | PE20030574A1 (https=) |
| PL (1) | PL208083B1 (https=) |
| PT (1) | PT1442030E (https=) |
| SI (1) | SI1442030T1 (https=) |
| SV (1) | SV2004001367A (https=) |
| TW (1) | TWI281916B (https=) |
| UA (1) | UA75716C2 (https=) |
| WO (1) | WO2003035629A1 (https=) |
| ZA (1) | ZA200403089B (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101624391A (zh) * | 2001-06-11 | 2010-01-13 | 病毒化学医药公司 | 用作黄病毒感染抗病毒剂的噻吩衍生物 |
| SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| AU2003249683A1 (en) * | 2002-06-06 | 2003-12-22 | Smithkline Beecham Corporation | Nf-:b inhibitors |
| US7402608B2 (en) * | 2002-12-10 | 2008-07-22 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of Flavivirus infections |
| SE0300092D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
| SE0300091D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
| US20050085531A1 (en) * | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| JP5134247B2 (ja) * | 2004-09-13 | 2013-01-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド含有化合物の血管新生阻害物質との併用 |
| EP2364699A1 (en) * | 2004-09-13 | 2011-09-14 | Eisai R&D Management Co., Ltd. | Joint use of sulfonamide based compound with angiogenesis inhibitor |
| US8772269B2 (en) | 2004-09-13 | 2014-07-08 | Eisai R&D Management Co., Ltd. | Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
| WO2006090927A1 (ja) * | 2005-02-28 | 2006-08-31 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物の摂食亢進作用 |
| PL1859793T3 (pl) * | 2005-02-28 | 2011-09-30 | Eisai R&D Man Co Ltd | Nowe połączone zastosowanie związku sulfonamidowego w leczeniu choroby nowotworowej |
| JPWO2006090928A1 (ja) * | 2005-02-28 | 2008-07-24 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド化合物の血管新生阻害物質との新規併用 |
| BRPI0610283A2 (pt) * | 2005-05-13 | 2010-10-19 | Virochem Pharma Inc | composto, uso do mesmo na preparação de um medicamento para o tratamento ou prevenção de uma infecção por vìrus de hepatite c, composição farmacêutica e combinação farmacêutica |
| US7208506B2 (en) * | 2005-07-07 | 2007-04-24 | Hoffmann-La Roche Inc. | Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| US7625896B2 (en) * | 2005-11-25 | 2009-12-01 | Hoffman-La Roche Inc. | Pyridylsulfonamide derivatives |
| US20100291592A1 (en) | 2006-04-20 | 2010-11-18 | Taro Semba | Novel marker for sensitivity against sulfonamide compound |
| US7939532B2 (en) * | 2006-10-26 | 2011-05-10 | Hoffmann-La Roche Inc. | Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| CA2670260A1 (en) | 2006-11-15 | 2008-05-22 | Virochem Pharma Inc. | Thiophene analogues for the treatment or prevention of flavivirus infections |
| US7879884B2 (en) | 2007-05-16 | 2011-02-01 | Hoffmann-La Roche Inc. | Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| CN101899008B (zh) * | 2010-05-20 | 2012-10-17 | 中国人民解放军第二军医大学 | N-取代嘧啶磺酰基-取代苯甲酰胺类化合物及其制备药物的用途 |
| CN103450149B (zh) * | 2012-06-01 | 2015-10-14 | 中国科学院上海有机化学研究所 | 苯基噻吩磺酰胺类化合物及其制备方法和用途 |
| JP6364967B2 (ja) * | 2014-05-30 | 2018-08-01 | 東ソー株式会社 | ジチエノベンゾジチオフェンの製造方法 |
| CN106588868A (zh) * | 2016-11-16 | 2017-04-26 | 武汉理工大学 | 一种2‑溴‑3‑噻吩甲酸中间体的合成方法 |
| CN108558822B (zh) * | 2018-06-01 | 2020-12-18 | 盐城锦明药业有限公司 | N-((5-溴噻吩-2-基)磺酰基)-2,4-二氯苯甲酰胺的合成方法 |
| CN110835345A (zh) * | 2018-08-17 | 2020-02-25 | 中国科学院上海药物研究所 | 一类细胞周期依赖性激酶的降解剂、其制备方法、药物组合物及其用途 |
| CN109265437A (zh) * | 2018-10-19 | 2019-01-25 | 凯莱英医药集团（天津）股份有限公司 | 一种3-羟基噻吩-2-羧酸酯类化合物的制备方法 |
| EP4724106A1 (en) * | 2023-06-07 | 2026-04-15 | Kræftens bekæmpelse | Protacs and hyt-pd molecules for targeted protein degradation of dcaf15 and their use in the treatment of amyloidosis |
| WO2025031361A1 (zh) * | 2023-08-09 | 2025-02-13 | 上海科技大学 | 磺酰胺类化合物作为制备治疗癌症药物的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA813332B (en) * | 1980-06-21 | 1982-05-26 | Pfizer | Larvicides and isecticides |
| IL98784A0 (en) | 1990-07-17 | 1992-07-15 | Lilly Co Eli | Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them |
| US5177074A (en) * | 1991-03-26 | 1993-01-05 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5169860A (en) * | 1992-03-13 | 1992-12-08 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| WO1998001440A2 (en) * | 1996-07-05 | 1998-01-15 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof |
| WO1998014440A1 (en) | 1996-10-04 | 1998-04-09 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| JP4316787B2 (ja) | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
-
2002
- 2002-10-11 TW TW091123452A patent/TWI281916B/zh not_active IP Right Cessation
- 2002-10-15 JP JP2003538145A patent/JP4464681B2/ja not_active Expired - Fee Related
- 2002-10-15 HU HU0401638A patent/HUP0401638A3/hu unknown
- 2002-10-15 AT AT02802117T patent/ATE338033T1/de active
- 2002-10-15 HR HRP20040371AA patent/HRP20040371B1/xx not_active IP Right Cessation
- 2002-10-15 NZ NZ531136A patent/NZ531136A/en not_active IP Right Cessation
- 2002-10-15 CN CNB028212150A patent/CN1298709C/zh not_active Expired - Fee Related
- 2002-10-15 EA EA200400582A patent/EA006081B1/ru not_active IP Right Cessation
- 2002-10-15 PL PL368234A patent/PL208083B1/pl not_active IP Right Cessation
- 2002-10-15 CA CA2463300A patent/CA2463300C/en not_active Expired - Fee Related
- 2002-10-15 WO PCT/US2002/031568 patent/WO2003035629A1/en not_active Ceased
- 2002-10-15 KR KR1020047006058A patent/KR100913471B1/ko not_active Expired - Fee Related
- 2002-10-15 DK DK02802117T patent/DK1442030T3/da active
- 2002-10-15 EP EP02802117A patent/EP1442030B1/en not_active Expired - Lifetime
- 2002-10-15 UA UA20040403046A patent/UA75716C2/uk unknown
- 2002-10-15 SI SI200230399T patent/SI1442030T1/sl unknown
- 2002-10-15 US US10/490,935 patent/US7084170B2/en not_active Expired - Fee Related
- 2002-10-15 BR BR0212386-0A patent/BR0212386A/pt not_active IP Right Cessation
- 2002-10-15 IL IL16085102A patent/IL160851A0/xx unknown
- 2002-10-15 MX MXPA04003886A patent/MXPA04003886A/es active IP Right Grant
- 2002-10-15 PT PT02802117T patent/PT1442030E/pt unknown
- 2002-10-15 ES ES02802117T patent/ES2269816T3/es not_active Expired - Lifetime
- 2002-10-15 AU AU2002334817A patent/AU2002334817B2/en not_active Ceased
- 2002-10-15 DE DE60214413T patent/DE60214413T2/de not_active Expired - Lifetime
- 2002-10-21 EG EG2002101152A patent/EG26021A/en active
- 2002-10-23 MY MYPI20023959A patent/MY130718A/en unknown
- 2002-10-23 AR ARP020104007A patent/AR037248A1/es active IP Right Grant
- 2002-10-24 SV SV2002001367A patent/SV2004001367A/es unknown
- 2002-10-25 PE PE2002001051A patent/PE20030574A1/es not_active Application Discontinuation
-
2004
- 2004-03-11 IL IL160851A patent/IL160851A/en not_active IP Right Cessation
- 2004-03-30 NO NO20041316A patent/NO20041316L/no not_active Application Discontinuation
- 2004-04-22 ZA ZA200403089A patent/ZA200403089B/en unknown
- 2004-04-23 EC EC2004005078A patent/ECSP045078A/es unknown
-
2006
- 2006-06-06 US US11/447,457 patent/US7250430B2/en not_active Expired - Fee Related
- 2006-11-16 CY CY20061101669T patent/CY1106247T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE338033T1 (de) | Thiophen- und thiazolsulfonamide als antineoplastische mittel | |
| ATE391531T1 (de) | Schweisshemmende mittel | |
| ATE392898T1 (de) | Antiphlogistische mittel | |
| DE60106275D1 (de) | Dermatologisches mittel | |
| DE50112013D1 (de) | Deodorantien und antiperspirantien | |
| EP1298180A4 (en) | HYDROPHOBIC AND LIPOPHOBE COMPOSITION | |
| EP1412378A4 (en) | APTAMERS AND ANTIAPTAMERS | |
| DE60234652D1 (de) | Verschleissteil und -anordnung | |
| ATE438637T1 (de) | Thiophenderivate als antivirale mittel gegen flavivirus-infektion | |
| ATE516030T1 (de) | Benzimidazolidinon-derivate als muscarinische mittel | |
| ATE550940T1 (de) | Synergische herbizide mittel | |
| DE10195939D2 (de) | Lageranordnung | |
| DE60133831D1 (de) | Verwendung von cci-779 als antineoplastisches mittel | |
| DE60204770D1 (de) | Scharnier | |
| DE60207318D1 (de) | Festes kosmetisches Mittel | |
| DE60230470D1 (de) | Festes kosmetisches Mittel | |
| DE60220505D1 (de) | Haarwaschmittel | |
| ATE343394T1 (de) | Endoparasitizide mittel | |
| ATE321761T1 (de) | Indolylpiperidinderivate als antihistaminische und antiallergische mittel | |
| FI112705B (fi) | Saranat | |
| DK1392670T3 (da) | Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater | |
| DE60136966D1 (de) | Pflanzenstärkendes mittel | |
| ATE287708T1 (de) | 1-amino-alkylcyclohexanederivate als trypanocide mittel | |
| EP1701736A4 (en) | THERAPEUTIC AGENTS AND USES | |
| DE60219418T8 (de) | Silanylphenole und -naphthole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1442030 Country of ref document: EP |